Health and Medicine
-
August 23, 2012
VU, Lipscomb partner on dual degree program
A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists. -
August 23, 2012
Gene linked to familial prostate cancer
A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows. -
August 16, 2012
Method may refine personalized trials for cancer therapy
A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments. -
August 16, 2012
African ancestry, stomach bug link
Socioeconomic factors, African ancestry linked to risk for cancer-causing infection. -
August 14, 2012
Flu Tool guides patient decision-making
Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources. -
August 10, 2012
Key to a woman’s heart (condition)?
Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity. -
August 9, 2012
New therapeutic target for cold, flu viruses identified
Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.